临床肝胆病杂志2013，Vol.29Issue(8)：576-580,5.DOI:10.3969/j.issn.1001-5256.2013.08.006
甲胎蛋白应答在肝细胞癌治疗中的预后价值
Prognostic value of α-fetoprotein response in treatment of hepatocellular carcinoma
贾佳 1祁兴顺 1韩国宏1
作者信息
- 1. 第四军医大学西京消化病医院消化介入科,西安710032
- 折叠
摘要
Abstract
Primary hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver.Accurate assessment of treatment outcome and prognosis in HCC patients is very important due to its high malignancy and poor prognosis.Currently,radiological imaging,though a standard method for prognostic evaluation of HCC,has a lot of limitations.As an important serological marker of HCC,alpha-fetoprotein (AFP) has been widely used in the screening,diagnosis,and prognostic evaluation of HCC.The studies regarding the prognostic value of AFP response in HCC patients were summarized.Generally,AFP has good prognostic value in HCC patients treated with radiofrequency ablation,transarterial chemoembolization,yttrium-90 radioembolization,molecular targeted agents like sorafenib,systemic chemotherapy,hepatic artery infusion chemotherapy,or concurrent chemoradiotherapy.关键词
癌,肝细胞/甲胎蛋白类/预后Key words
carcinoma, hepatocellular/ alpha-fetoproteins/ prognosis分类
医药卫生引用本文复制引用
贾佳,祁兴顺,韩国宏..甲胎蛋白应答在肝细胞癌治疗中的预后价值[J].临床肝胆病杂志,2013,29(8):576-580,5.
